The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
Status:
Completed
Trial end date:
2019-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate efficacy of cobitolimod treatment at different dose
levels and frequencies compared to placebo in patients with moderate to severe left-sided
ulcerative colitis.